Treatment Indications: structural facial contouring and volumizing in high‑support zones (cheekbones, chin, jawline, nasal bridge);, correction of severe volume loss and deep facial depressions;, non‑surgical rhinoplasty and jawline definition;, creation of a lifting effect via deep‑layer volumization;, restoration of facial architecture and symmetry in cases of pronounced atrophy
Release form: 1 × 1.1 mL pre‑filled sterile glass syringe
Indications: volumizing and structural contouring in deep subcutaneous and supraperiosteal layers;, restoration of major volume deficits and facial skeletal support;, smoothing deep depressions and folds with maximum gel stability and viscoelasticity;, achieving long‑term architectural reshaping with minimal product migration (effect duration ~12–24 months)